ProfileGDS4718 / 208739_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 95% 94% 94% 95% 97% 96% 95% 96% 96% 96% 94% 97% 97% 96% 96% 97% 96% 95% 94% 95% 95% 95% 96% 94% 97% 96% 93% 94% 96% 90% 96% 93% 95% 96% 98% 95% 95% 95% 94% 96% 95% 95% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.256795
GSM549102patient 115, normal, homogenized [OPG study]10.330895
GSM549104patient 119, normal, homogenized [OPG study]10.115194
GSM549108patient 138, normal, homogenized [OPG study]10.050294
GSM549119patient 077, normal, homogenized [OPG study]10.401295
GSM549133patient 032, cancer, homogenized [OPG study]10.798197
GSM549139patient 042, cancer, homogenized [OPG study]10.639196
GSM549099patient 107, normal, homogenized [OPG study]10.300495
GSM549109patient 139, normal, homogenized [OPG study]10.552296
GSM549110patient 046, normal, homogenized [OPG study]10.666596
GSM549114patient 063, normal, homogenized [OPG study]10.827896
GSM549122patient 082, normal, homogenized [OPG study]10.113394
GSM549134patient 033, cancer, homogenized [OPG study]10.738197
GSM549136patient 036, cancer, homogenized [OPG study]10.799597
GSM549140patient 044, cancer, homogenized [OPG study]10.511996
GSM549111patient 047, normal, homogenized [OPG study]10.685396
GSM549113patient 057, normal, homogenized [OPG study]10.983697
GSM549132patient 031, cancer, homogenized [OPG study]10.351496
GSM549137patient 038, cancer, homogenized [OPG study]10.117495
GSM549142patient 047, cancer, homogenized [OPG study]9.5379394
GSM549100patient 110, normal, homogenized [OPG study]10.311695
GSM549107patient 135, normal, homogenized [OPG study]10.271395
GSM549115patient 068, normal, homogenized [OPG study]10.538795
GSM549116patient 072, normal, homogenized [OPG study]10.760196
GSM549120patient 078, normal, homogenized [OPG study]10.160494
GSM549131patient 030, cancer, homogenized [OPG study]10.905997
GSM549118patient 074, normal, homogenized [OPG study]10.471496
GSM549129patient 027, cancer, homogenized [OPG study]9.6845893
GSM549123patient 088, normal, homogenized [OPG study]10.132594
GSM549124patient 006, cancer, homogenized [OPG study]10.282496
GSM549126patient 015, cancer, homogenized [OPG study]9.2149490
GSM549128patient 025, cancer, homogenized [OPG study]10.572696
GSM549103patient 117, normal, homogenized [OPG study]9.7995993
GSM549117patient 073, normal, homogenized [OPG study]10.411495
GSM549138patient 041, cancer, homogenized [OPG study]10.616196
GSM549141patient 045, cancer, homogenized [OPG study]11.186798
GSM549130patient 028, cancer, homogenized [OPG study]9.9419995
GSM549101patient 111, normal, homogenized [OPG study]10.177695
GSM549105patient 128, normal, homogenized [OPG study]10.350495
GSM549106patient 134, normal, homogenized [OPG study]10.174894
GSM549112patient 048, normal, homogenized [OPG study]10.755796
GSM549125patient 011, cancer, homogenized [OPG study]10.083495
GSM549127patient 024, cancer, homogenized [OPG study]9.9965895
GSM549135patient 035, cancer, homogenized [OPG study]10.582296